We are live on ! Find out more
IBIO icon

iBio
IBIO

20 hedge funds and large institutions have $1.99M invested in iBio in 2014 Q4 according to their latest regulatory filings, with 15 funds opening new positions, 1 increasing their positions, 2 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

400% more first-time investments, than exits

New positions opened: 15 | Existing positions closed: 3

122% more funds holding

Funds holding: 9 → 20 (+11)

113% more capital invested

Capital invested by funds: $937K → $1.99M (+$1.06M)

0% more ownership

Funds ownership: 0% → 0% (+0%)

50% less repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 2

Holders
20
Holders Change
+11
Holders Change %
+122.22%
% of All Funds
0.53%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
15
Increased
1
Reduced
2
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Renaissance Technologies
Renaissance Technologies
New York
+$502K
2
Vanguard Group
Vanguard Group
Pennsylvania
+$400K
3
S
SignatureFD
Georgia
+$166K
4
Citadel Advisors
Citadel Advisors
Florida
+$107K
5
BIT
BlackRock Institutional Trust
California
+$90.8K

Top Sellers

Rank Fund Capital Flow
1
VKH
Virtu KCG Holdings
New York
-$53.4K
2
GHA
GW Henssler & Associates
Georgia
-$11K
3
Millennium Management
Millennium Management
New York
-$9K
4
State Street
State Street
Massachusetts
-$5.34K
5
TDC
Thompson Davis & Co
Virginia
-$3K

IBIO Hedge Fund Activity: Q4 2014 in Review

20 of the 3,765 institutional investors tracked by Wall St. Rank reported a position in iBio (IBIO) for Q4 2014, worth a combined $1.99M — up 113% from $937K a quarter earlier.

Buyers outnumbered sellers: 15 funds opened new IBIO positions and 3 closed out — a net gain of 12 holders — while 1 added to existing stakes and 2 trimmed.

The largest buyer was Renaissance Technologies, opening a new position worth an estimated $502K. The largest seller was Virtu KCG Holdings, cutting an estimated $53.4K.

  • 20 institutional investors held iBio (IBIO) as of Q4 2014, up from 9 in Q3 2014.
  • Funds reported $1.99M of iBio stock for Q4 2014, up 113% quarter-over-quarter.
  • 15 funds opened new iBio positions in Q4 2014 and 3 closed out, a net change of +12 holders.
  • The largest iBio buyer in Q4 2014 was Renaissance Technologies, an estimated $502K added.
  • The largest iBio seller in Q4 2014 was Virtu KCG Holdings, an estimated $53.4K sold.

Based on aggregated 13F filings for Q4 2014.